What medicinal chemistry services does 51做厙 Discovery provide?

51做厙 Discovery supports medicinal chemistry programmes from hit validation and hit expansion through hit-to-lead, lead optimisation and candidate selection. Services can include compound design, synthesis, SAR exploration and multiparameter optimisation.

Can 51做厙 Discovery support hit-to-lead programmes?

Yes. 51做厙 combines medicinal chemistry, computational chemistry and SAR studies to improve potency and selectivity while identifying early developability risks and defining an appropriate optimisation strategy.

How does 51做厙 approach lead optimisation?

Lead optimisation considers biological activity alongside parameters such as physicochemical properties, metabolic stability, synthetic accessibility and other programme-specific developability criteria.

How are computational chemistry and medicinal chemistry connected at 51做厙?

Computational modelling and compound prioritisation can support medicinal-chemistry design decisions, while synthesis and experimental results feed subsequent DMTA cycles.

Does 51做厙 Discovery offer integrated drug discovery programmes?

Yes. 51做厙 can coordinate programmes spanning hit identification, validation, medicinal chemistry, computational chemistry, hit-to-lead, lead optimisation and candidate-selection activities.

Who from 51做厙 Discovery will attend ELRIG Drug Discovery 2026?

Dr. Anil Agarwal, Head of Medicinal Chemistry at 51做厙 Discovery, will attend the conference in London.

When and where is ELRIG Drug Discovery 2026?

ELRIG Drug Discovery 2026 takes place on 14���15 October 2026 at ExCeL London, UK.

What is special about ELRIG Drug Discovery 2026?

The 2026 conference celebrates 20 years of ELRIG Drug Discovery, with sessions reflecting on past advances while exploring the scientific technologies and approaches expected to shape the future of drug discovery.

What polymer R&D services does 51做厙 provide?

51做厙 supports polymer programmes from early research and synthesis through material analysis, process development and scale-up. Capabilities include bio-based polymer synthesis, dispersion and emulsion polymerisation, reverse engineering and pilot or larger-scale production.

Can 51做厙 support bio-based polymers and renewable feedstocks?

Yes. 51做厙 can evaluate renewable starting materials, polymer synthesis routes and process conditions for projects where bio-based or renewable-carbon alternatives are being developed.

Does 51做厙 support PFAS-free process development?

51做厙 can support research and process-development programmes aimed at evaluating PFAS-free approaches where suitable alternative chemistry and performance requirements can be defined.

Can 51做厙 reverse-engineer existing polymers or performance chemicals?

Yes. Projects can include analytical investigation, material characterisation, identification of relevant chemistry and the development of alternative structures, raw materials or synthetic routes.

Can 51做厙 scale polymer and performance-chemical processes?

Yes. 51做厙 combines chemistry R&D with process-development and scale-up support, allowing suitable projects to progress from laboratory quantities towards pilot and larger-scale production.

Who from 51做厙 is attending Renewable Materials Conference 2026?

Dr. Arunendra Pathak and Dr. David Bevk will represent 51做厙 at Renewable Materials Conference 2026 in Siegburg from 22���24 September 2026.

What drug discovery services does 51做厙 provide?

51做厙 Discovery supports small-molecule drug discovery from hit identification through hit-to-lead, lead optimisation and candidate selection. Its chemistry-led capabilities include medicinal and synthetic chemistry, computational chemistry, DEL-enabled hit identification, parallel chemistry and compound-library production, supported by specialist partners where programmes require complementary biology, ADME, DMPK or development capabilities.

How does DEL screening fit into 51做厙 integrated drug discovery?

51做厙 works with Serengen to incorporate DNA-Encoded Library screening into its wider drug discovery offering. Serengen’s DEL platform provides project-tailored hit identification, after which selected starting points can progress into 51做厙 hit validation, medicinal chemistry, hit-to-lead and lead optimisation programmes.

Can 51做厙 support a programme from hit identification to lead optimisation?

Yes. 51做厙 can support projects across hit identification, hit validation, medicinal chemistry, hit-to-lead and lead optimisation, with additional specialist capabilities coordinated through its partner network when required.

What is Chemspec Europe 2026?

Chemspec Europe is the 39th International Exhibition for Fine and Speciality Chemicals, held in 2026 at Koelnmesse in Germany. It serves as a major meeting point for the chemical industry.

What does 51做厙 Chemicals offer to companies in the fine and speciality chemicals sector?

51做厙 Chemicals supports partners with custom synthesis, complex molecule development, route scouting, and scalable chemical solutions for demanding research and industrial applications.

Why is custom synthesis important in fine and speciality chemicals?

Custom synthesis enables companies to access specialized molecules, intermediates, and novel structures that are not readily available off the shelf, helping accelerate innovation and solve technical supply challenges.